Development of Novel Technologies for the Synthesis of Biodegradable Pegylated Nanoparticles
Polymeric injectable carriers, able to deliver drugs or other compounds to specific sites of action for a prolonged time, represent a potential therapeutic approach for several diseases. However, therapeutic activity is compromised by particle recognition by the macrophages of the mononuclear phagocyte system (MPS) and their elimination within seconds, or minutes after intravenous injection. Blood proteins (opsonins) adsorb onto the particles surface, making them recognizable to the macrophages of the MPS.
KeywordsAnionic Polymerization Polymerization Medium Mononuclear Phagocyte System Amphiphilic Copolymer Surface Chemical Analysis
Unable to display preview. Download preview PDF.
- Müller, B.G., and Kissel, T., 1993, Camouflage nanospheres: a new approach to bypassing phagocytic blood clearance by surface modified particulate carriers, Pharm. Pharmacol Lett., 3:67.Google Scholar
- Peracchia, M.T., Vauthier, C., Popa, M., Puisieux, F., and Couvreur, P., 1997c, An investigation on the formation of sterically stabilized PEG-PIBCA nanoparticles by chemical grafting of PEG during the polymerization of isobutyl cyanoacrylate, S.T.P. Pharma Sci., 7:514.Google Scholar
- Peracchia, M.T., Desmaële, D., Appel, M., d’Angelo, J. and Couvreur, P., 1997f, Biodegradable PEG-coated nanoparticles from a novel poly(MePEGcyanoacrylate-co-alkyl cyanoacrylate) amphiphilic copolymer, Proceed. Intern. Symp. on Control Rel of Bioact. Mater., 24:124.Google Scholar